V. Asymptomatic cerebrovascular diseases

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 4 SUPPL., 2011, Pages

  Shinohara, Yukito ^a,h   Yanagihara, Takehiko ^b   Abe, Koji ^c   Yoshimine, Toshiki ^b   Fujinaka, Toshiyuki ^d   Chuma, Takayo ^e   Ochi, Fumio ^f   Nagayama, Masao ^g   Ogawa, Akira ⁱ   Suzuki, Norihiro ^j   Katayama, Yasuo ^k   Kimura, Akio ^j   Kayama, Takamasa ^d  

^a Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e Shiga Medical Center for Adult Diseases   (Japan)

^f Self Defense Forces Central Hospital   (Japan)

^g International University of Health and Welfare   (Japan)

^h Japan Stroke Society   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j KEIO UNIVERSITY   (Japan)

^k NIPPON MEDICAL SCHOOL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN DYSFUNCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BYPASS SURGERY; CAROTID ARTERY BIFURCATION; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; CRANIOTOMY; DOPPLER ECHOGRAPHY; DRUG EFFECT; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; STROKE; WHITE MATTER;

EID: 80051766534     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.012     Document Type: Article

References (160)

1. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: The Cardiovascular Health Study. Neurology 2001;57:1222-1229 (Pubitemid 32947380)
2. Iwamoto H, Kiyohara Y, FujishimaM, et al. Prevalence of intracranial saccularaneurysms ina Japanese communitybased on a consecutive autopsy series during a 30-year observation period: The Hisayama Study. Stroke 1999;30:1390-1395 (Pubitemid 29296066)
3. Hop JW, Rinkel GJ, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997;28:660-664 (Pubitemid 27118394)
4. Roos YB, de Haan RJ, Beenen LF, et al. Complications andoutcome in patients with aneurysmal subarachnoid haemorrhage: A prospective hospital based cohort study in The Netherlands. J Neurol Neurosurg Psychiatry 2000;68:337-341 (Pubitemid 30248708)
5. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001;124(Pt 2):249-278 (Pubitemid 32142399)
6. Japanese Society for Detecting Asymptomatic Cerebral Diseases. Guidelines for brain check-up 2008, third revision. Sapporo: Kyobunsha; 2008 (in Japanese)
7. Sawada T, Oita J, Okamoto K, et al. Study on diagnostic criteria of asymptomatic cerebrovascular diseases. Jpn J Stroke 1997;19:489-493 (in Japanese)
8. Longstreth WT Jr, Bernick C, Manolio TA, et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225
9. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: The Cardiovascular Health Study. Neurology 2001;57:1222-1229 (Pubitemid 32947380)
10. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 2003;34:1126-1129 (Pubitemid 36547501)
11. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222 (Pubitemid 36359297)
12. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol 2007;6: 611-619 (Pubitemid 46921055)
13. Shinohara Y. Treatment strategy for cerebrovascular disease and its future: Pathophysiological study and EBM. Neuro Ther 1999;16:575-582 (in Japanese)
14. Uchiyama S, Hara Y, Maruyama S, et al. Platelet activation and large vessel disease in patients with silent cerebral infarction. Jpn J Stroke 1994;16:456-461 (in Japanese)
15. Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997;28:1932-1939 (Pubitemid 27458998)
16. Shinohara Y, Tohgi H, Hirai S, et al. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study), 1: Design and results at enrollment. Cerebrovasc Dis 2007;24:202-209 (Pubitemid 47295584)
17. Hart RG, Halperin JL, McBride R, et al. Aspirin for the primary prevention of stroke and other major vascular events: Meta-analysis andhypotheses.ArchNeurol 2000;57:326-332 (Pubitemid 30140518)
18. Kwon HM, Kim BJ, Lee SH, et al. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 2006;37:466-470
19. Inoue T, Fushimi H, Yamada Y, et al. The changes of lacunar state during a 5-year period in NIDDM. Diabetes Res Clin Pract 1998;42:155-160 (Pubitemid 29009775)
20. Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: A prospective cohort study. J Stroke Cerebrovasc Dis 2006;15:57-63 (Pubitemid 43324967)
21. Nakagawa T, Sekizawa K, Nakajoh K, et al. Silent cerebral infarction: A potential risk for pneumonia in the elderly. J Intern Med 2000;247:255-259 (Pubitemid 30108360)
22. Yanai I, Fujikawa T, Horiguchi J, et al. The 3-year course and outcome of patients with major depression and silent cerebral infarction. J Affect Disord 1998;47:25-30 (Pubitemid 28066755)
23. Ito S, Kono M, Komatsu K, et al. Is carotid atherosclerosis an index of systemic atherosclerosis? Ther Res 1998;19:379-392 (in Japanese)
24. Japanese Society for Detecting Asymptomatic Cerebral Disease. Guidelines for brain check-up 2008, third revision. Sapporo: Kyobunsha; 2008 (in Japanese)
25. Schmidt R, Fazekas F, Kapeller P, et al. MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study. Neurology 1999;53:132-139 (Pubitemid 29329661)
26. Kobayashi S. Clinical significance of asymptomatic cerebral infarction. Adv Neuro Sci 2001;45:450-460 (in Japanese)
27. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 2003;34:1126-1129 (Pubitemid 36547501)
28. Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74 (Pubitemid 34705520)
29. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability Study. Stroke 2008;39:1414-1420
30. Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: A prospective cohort study. J Stroke Cerebrovasc Dis 2006;15:57-63 (Pubitemid 43324967)
31. Shinohara Y, Tohgi H, Hirai S, et al. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study), 1: Design and results at enrollment. Cerebrovasc Dis 2007;24:202-209 (Pubitemid 47295584)
32. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995;26:1593-1597
33. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572 (Pubitemid 37430158)
34. Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-978 (Pubitemid 47366050)
35. Wright CB, Paik MC, Brown TR, et al. Total homocysteine is associated with white matter hyperintensity volume: The Northern Manhattan Study. Stroke 2005;36:1207-1211 (Pubitemid 40798740)
36. Censori B, Partziguian T, Manara O, et al. Plasma homocysteine and severe white matter disease. Neurol Sci 2007;28:259-263 (Pubitemid 350055435)
37. OBrien J, Ames D, Chiu E, et al. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow-up study. BMJ 1998;317:982-984 (Pubitemid 28457258)
38. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-151 (Pubitemid 30078560)
39. OBrien JT, Desmond P, Ames D, et al. Magnetic resonance imaging correlates of memory impairment in the healthy elderly: Association with medial temporal lobe atrophy but not white matter lesions. Int J Geriatr Psychiatry 1997;12:369-374 (Pubitemid 27148460)
40. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral smallvessel disease and decline in information processing speed, executive function and memory. Brain 2005;128: 2034-2041 (Pubitemid 41253271)
41. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small-vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 2008;39:2712-2719
42. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk in Communities Study. Neurology 2005;64: 2056-2062 (Pubitemid 40880992)
43. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 2005;36:56-61 (Pubitemid 40054175)
44. Doddy RS, Massman PJ, Mawad M, et al. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimers disease: Comparison to smallvessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:191-199 (Pubitemid 28537813)
45. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643-647 (Pubitemid 32295717)
46. Fukuda H, Kobayashi S, Okada K, et al. Frontal white matter lesions and dementia in lacunar infarction. Stroke 1990;21:1143-1149 (Pubitemid 20255408)
47. Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: The Rotterdam Study. Stroke 1994;25:1109-1115 (Pubitemid 24164747)
48. Nakajima Y, Ohsuga H, Yamamoto M, et al. Asymptomatic cerebral hemorrhage detected by MRI. Rinsho Shinkeigaku 1991;31:270-274 (in Japanese)
49. Shinohara Y. Asymptomatic intracerebral hemorrhage: Cases detected by MRI. Jpn J Clin Med 1993;51:272-275 (in Japanese)
50. Okada Y, Sadoshima S, Saku Y, et al. Silent cerebrovascular lesions in patients with symptomatic brain hemorrhage: Analysis on high-field magnetic resonance imaging. Jpn J Stroke 1992;14:187-191
51. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996;17: 573-578 (Pubitemid 26101967)
52. Kawano H, Suzuki Y, Yoneyama T, et al. Is cerebral hemorrhage approaching?. Progr Comput Imaging 2001;23:203-206 (in Japanese)
53. Takahashi W, Ohnuki T, Ide M, et al. Clinical characteristics in normal healthy adults with microbleeds on echoplanar gradient-echo T2*-weighted MRI. Jpn J Stroke 2004;26:357-363 (in Japanese)
54. Kadowaki H, Yamaguchi S, Bokura H, et al. Longitudinal study of cerebral microbleeds in patients with acute ischemic stroke. Jpn J Stroke 2005;27:311-316 (in Japanese)
55. Alemany M, Stenborg A, Terent A, et al. Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: Correlation with signs of microangiopathy and clinical data. Radiology 2006;238:240-247 (Pubitemid 43010601)
56. Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*-weighted MRI: Correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536-1540 (Pubitemid 34619953)
57. Wardlaw JM, Lewis SC, Keir SL, et al. Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke 2006;37:2633-2636 (Pubitemid 44454690)
58. Tajitsu K, Yokoyama S, Taguchi Y, et al. The correlation between lacunes and microbleeds on magnetic resonance imaging in consecutive 180 patients. Neuro Surg 2006;34:483-489 (in Japanese) (Pubitemid 43762767)
59. Imaizumi T, Horita Y, Hashimoto Y, et al. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: A prospective study. J Neurosurg 2004;101:915-920 (Pubitemid 43186441)
60. Fan YH, Zhang L, Lam WW, et al. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003;34:2459-2462 (Pubitemid 37221963)
61. Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004;127:2265-2275 (Pubitemid 39382235)
62. Derex L, Nighoghossian N, Hermier M, et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004;17:238-241 (Pubitemid 38529204)
63. Kakuda W, Thijs VN, Lansberg MG, et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005;65:1175-1178 (Pubitemid 41508206)
64. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: An emerging application. Stroke 2002;33: 95-98 (Pubitemid 34052192)
65. Fiehler J, Albers GW, Boulanger JM, et al. Bleeding Risk Analysis in Stroke Imaging before Thrombolysis (BRASIL): Pooled analysis of T2-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38: 2738-2744 (Pubitemid 47494012)
66. EC/IC Bypass Study Group. International Cooperative Study of Extracranial/Intracranial Arterial Anastomosis (EC/IC Bypass Study): Methodology and entry characteristics. Stroke 1985;16:397-406
67. EC/IC Bypass Study Group. Failure of extracranialintracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med 1985;313:1191-1200
68. Haynes RB, Mukherjee J, Sackett DL, et al. Functional status changes following medical or surgical treatment for cerebral ischemia: Results of the extracranial-intracranial bypass study. JAMA 1987;257:2043-2046 (Pubitemid 17056744)
69. Kremer C, Schaettin T, Georgiadis D, et al. Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry 2004;75:1300-1303 (Pubitemid 39141338)
70. Segura T, Serena J, Castellanos M, et al. Embolism in acute middle cerebral artery stenosis.Neurology2001;56:497-501 (Pubitemid 32172875)
71. Takagi Y, Hashimoto N, Iwama T, et al. Improvement of oxygen metabolic reserve after extracranial-intracranial bypass surgery in patients with severe haemodynamic insufficiency. Acta Neurochir (Wien) 1997;139:52-57 (Pubitemid 27052864)
72. Ogawa A; JET Study Group. EBM for Cerebrovascular Surgery in Japan: The JET Study. Jpn J Neurosurg 2001;10:596-603 (Pubitemid 32899600)
73. Suematsu Y, Nakano K, Sasako Y, et al. Conventional coronary artery bypass grafting in patients with total occlusion of the internal carotid artery. Heart Vessels 2000;15:256-262 (Pubitemid 33114963)
74. Cote R, Battista RN, Abrahamowicz M, et al. Asymptomatic Cervical Bruit Study Group. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. Ann Intern Med 1995;123:649-655
75. Kakkos SK, Nicolaides A, Griffin M, et al. Factors associated with mortality in patients with asymptomatic carotid stenosis: Results. Int Angiol 2005;24:221-230 (Pubitemid 41582329)
76. Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: A metaanalysis of randomized controlled trials. Stroke 2006;37: 1933-1940 (Pubitemid 44297754)
77. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909 (Pubitemid 39565192)
78. Mazzone T, Meyer PM, Feinstein SB, et al. Effect of pioglitazone compared with glimepiride on carotid intimamedia thickness in type 2 diabetes: A randomized trial. JAMA 2006;296:2572-2581 (Pubitemid 44903861)
79. Hobson RW 2nd, Weiss DG, Fields WS, et al. Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993;328:221-227 (Pubitemid 23035306)
80. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428
81. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004;363:1491-1502
82. Baker WH, Howard VJ, Howard G, et al; ACAS Investigators. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke 2000;31:2330-2334
83. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501
84. CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 2005;42: 213-219
85. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: The ARCHeR results. J Vasc Surg 2006;44:258-268 (Pubitemid 44142925)
86. White CJ, Iyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: The BEACH Trial 30-day results. Catheter Cardiovasc Interv 2006;67: 503-512
87. Iyer SS, White CJ, Hopkins LN, et al. Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol 2008;51:427-434
88. Safian RD, Bresnahan JF, Jaff MR, et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 2006;47:2384-2389 (Pubitemid 43866375)
89. Hill MD, Morrish W, Soulez G, et al. Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis. AJNR Am J Neuroradiol 2006;27:759-765 (Pubitemid 44897718)
90. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: Predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007;70: 1025-1033
91. Paciaroni M, Caso V, Acciarresi M, et al. Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical procedures. J Neurol Neurosurg Psychiatry 2005;76:1332-1336 (Pubitemid 41360966)
92. Ghosh J, Murray D, Khwaja N, et al. The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery. Eur J Vasc Endovasc Surg 2005;29:88-90 (Pubitemid 39618998)
93. Yamada S, Takagi Y, Nozaki K, et al. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg 2007;107:965-972 (Pubitemid 350255210)
94. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: Natural history and treatment paradigm. J Neurosurg 2003;98:3-7 (Pubitemid 36050440)
95. Hartmann A, Mast H, Choi JH, et al. Treatment of arteriovenous malformations of the brain. Curr Neurol Neurosci Rep 2007;7:28-34 (Pubitemid 46188772)
96. Stapf C, Mast H, Sciacca RR, et al. The New York Islands AVM Study: Design, study progress, and initial results. Stroke 2003;34:e29-e33
97. Fleetwood IG, Marcellus ML, Levy RP, et al. Deep arteriovenous malformations of the basal ganglia and thalamus: Natural history. J Neurosurg 2003;98:747-750 (Pubitemid 36401551)
98. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350-1355 (Pubitemid 43739643)
99. Bristol RE, Albuquerque FC, Spetzler RF, et al. Surgical management of arteriovenous malformations in children. J Neurosurg 2006;105(2 Suppl):88-93 (Pubitemid 44954778)
100. Khaw AV, Mohr JP, Sciacca RR, et al. Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004;35:660-663 (Pubitemid 38280837)
101. Zipfel GJ, Bradshaw P, Bova FJ, et al. Do the morphological characteristics of arteriovenous malformations affect the results of radiosurgery? J Neurosurg 2004;101:393-401 (Pubitemid 39100714)
102. Stefani MA, Porter PJ, ter Brugge KG, et al. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 2002;33:1220-1224 (Pubitemid 34517039)
103. Stapf C, Mohr JP, Pile-Spellman J, et al. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation. J Neurol Neurosurg Psychiatry 2002;73:294-298
104. Jayaraman MV, Marcellus ML, Do HM, et al. Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: Is treatment justified? Stroke 2007;38:325-329 (Pubitemid 46184303)
105. Wilkins RH. Natural history of intracranial vascular malformations: A review. Neurosurgery 1985;16:421-430 (Pubitemid 15110015)
106. Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 2006;37: 1243-1247 (Pubitemid 43731870)
107. Sanchez-Mejia RO, Chennupati SK, Gupta N, et al. Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 2006;105(2 Suppl):82-87 (Pubitemid 44954777)
108. Nicolato A, Foroni R, Crocco A, et al. Gamma knife radiosurgery in the management of arteriovenous malformations of the basal ganglia region of the brain. Minim Invasive Neurosurg 2002;45:211-223 (Pubitemid 36098189)
109. Andrade-Souza YM, Zadeh G, Scora D, et al. Radiosurgery for basal ganglia, internal capsule, and thalamus arteriovenous malformation: Clinical outcome. Neurosurgery 2005;56:56-64
110. Nicolato A, Foroni R, Seghedoni A, et al. Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients. Childs Nerv Syst 2005;21:301-308
111. Cohen-Gadol AA, Pollock BE. Radiosurgery for arteriovenous malformations in children. J Neurosurg 2006;104(6 Suppl):388-391 (Pubitemid 44954812)
112. Reyns N, Blond S, Gauvrit JY, et al. Role of radiosurgery in the management of cerebral arteriovenous malformations in the pediatric age group: Data from a 100- patient series. Neurosurgery 2007;60:268-276
113. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005;352:146-153 (Pubitemid 40096611)
114. Yu SC, Chan MS, Lam JM, et al. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: Initial success and rate of permanent cure. AJNR Am J Neuroradiol 2004;25:1139-1143 (Pubitemid 39095156)
115. Taylor CL, Dutton K, Rappard G, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 2004;100:810-812 (Pubitemid 38533963)
116. White PM, Wardlaw JM, Easton V. Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review. Radiology 2000;217:361-370
117. Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med 1999;341: 1344-1350
118. Yoshimoto Y, Wakai S. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms: A mathematical model. Stroke 1999;30: 1621-1627 (Pubitemid 29379613)
119. King JT Jr, Yonas H, Horowitz MB, et al. A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons. J Neurol Neurosurg Psychiatry 2005;76: 550-554 (Pubitemid 40486582)
120. Otawara Y, Ogasawara K, Kubo Y, et al. Anxiety before and after surgical repair in patients with asymptomatic unruptured intracranial aneurysm. Surg Neurol 2004;62: 28-31 (Pubitemid 38850196)
121. van der Schaaf IC, Brilstra EH, Rinkel GJ, et al. Quality of life, anxiety, and depression in patients with an untreated intracranial aneurysm or arteriovenous malformation. Stroke 2002;33:440-443 (Pubitemid 34123384)
122. van der Schaaf IC, Wermer MJ, Velthuis BK, et al. Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry 2006;77: 748-752 (Pubitemid 43837202)
123. Rinkel GJ, Djibuti M, Algra A, et al. Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke 1998;29:251-256 (Pubitemid 28046972)
124. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: Probability of and risk factors for aneurysm rupture. J Neurosurg 2000;93:379-387
125. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: Risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725-1733
126. Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103-110 (Pubitemid 36831019)
127. Asari S, Ohmoto T. Natural history and risk factors of unruptured cerebral aneurysms. Clin Neurol Neurosurg 1993;95:205-214 (Pubitemid 23288237)
128. Yasui N, Suzuki A, Nishimura H, et al. Long-term followup study of unruptured intracranial aneurysms. Neurosurgery 1997;40:1155-1160 (Pubitemid 27251666)
129. Morita A, Fujiwara S, Hashi K, et al. Risk of rupture associated with intact cerebral aneurysms in the Japanese population: A systematic review of the literature from Japan. J Neurosurg 2005;102:601-606 (Pubitemid 43186662)
130. Wermer MJ, van der Schaaf IC, Algra A, et al. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: An updated meta-analysis. Stroke 2007;38:1404-1410 (Pubitemid 351664233)
131. Ujiie H, Tamano Y, Sasaki K, et al. Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm? Neurosurgery 2001;48:495-503 (Pubitemid 32199597)
132. Raghavan ML,MaB, Harbaugh RE. Quantified aneurysm shape and rupture risk. J Neurosurg 2005;102:355-362 (Pubitemid 43194088)
133. Ingall T, Asplund K, Mahonen M, et al. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000;31: 1054-1061 (Pubitemid 30253525)
134. Morita A. Online outcome study of unruptured cerebral aneurysm in Japan (UCAS Japan). Rinsho Shinkeigaku 2002;42:1188-1190 (in Japanese) (Pubitemid 36612263)
135. Yonekura M. Small unruptured aneurysm verification (SUAVe Study, Japan): Interim report. Neurol Med Chir (Tokyo) 2004;44:213-214 (Pubitemid 38619409)
136. Phan TG, Huston J 3rd, Brown RD Jr, et al. Intracranial saccular aneurysm enlargement determined using serial magnetic resonance angiography. J Neurosurg 2002;97: 1023-1028 (Pubitemid 35253536)
137. Matsubara S, Hadeishi H, Suzuki A, et al. Incidence and risk factors for the growth of unruptured cerebral aneurysms: Observation using serial computerized tomography angiography. J Neurosurg 2004;101:908-914 (Pubitemid 43186440)
138. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: A long-term follow- up study. Stroke 2001;32:485-491 (Pubitemid 32155239)
139. Cheong JJ, Ghinea N, van Gelder JM. Estimating the annual rate of de novo multiple aneurysms: Three statistical approaches. Neurosurg Focus 2004;17:E8. (http://thejns. org/doi/pdf/10.3137/foc.2004.17.5.8)
140. Chang HS. Simulation of the natural history of cerebral aneurysms based on data from the International Study of Unruptured Intracranial Aneurysms. J Neurosurg 2006;104:188-194
141. Horikoshi T, Akiyama I, Yamagata Z, Nukui H. Retrospective analysis of the prevalence of asymptomatic cerebral aneurysm in 4518 patients undergoing magnetic resonance angiography: When does cerebral aneurysm develop? Neurol Med Chir (Tokyo) 2002;42:105-113
142. Wirth FP, Laws ER Jr, Piepgras D, et al. Surgical treatment of incidental intracranial aneurysms. Neurosurgery 1983;12:507-511 (Pubitemid 13097043)
143. Raaymakers TW, Rinkel GJ, Limburg M, et al. Mortality and morbidity of surgery for unruptured intracranial aneurysms: A meta-analysis. Stroke 1998;29: 1531-1538 (Pubitemid 28365569)
144. King JT Jr, Glick HA, Mason TJ, et al. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: A cost-effectiveness analysis. J Neurosurg 1995;83: 403-412
145. Otawara Y, Ogasawara K, Ogawa A, et al. Cognitive function before and after surgery in patients with unruptured intracranial aneurysm. Stroke 2005;36:142-143 (Pubitemid 40054190)
146. Raaymakers TW, on behalf of the MARS Study Group. Functional outcome and quality of life after angiography and operation for unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2000;68:571-576 (Pubitemid 30248820)
147. Brilstra EH, Rinkel GJ, van der Graaf Y, et al. Quality of life after treatment of unruptured intracranial aneurysms by neurosurgical clipping or by embolisation with coils: A prospective, observational study. Cerebrovasc Dis 2004;17:44-52 (Pubitemid 38145907)
148. Yamashiro S, Nishi T, Koga K, et al. Improvement of quality of life in patients surgically treated for asymptomatic unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2007;78:497-500 (Pubitemid 46662898)
149. Chang HS, Kirino T. Quantification of operative benefit for unruptured cerebral aneurysms: A theoretical approach. J Neurosurg 1995;83:413-420
150. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology 1999;52:1806-1815 (Pubitemid 29260893)
151. Aoki N, Kitahara T, Fukui T, et al. Management of unruptured intracranial aneurysm in Japan: A Markovian decision analysis with utility measurements based on the Glasgow Outcome Scale. Med Decis Making 1998;18: 357-364 (Pubitemid 28465275)
152. Aoki N, Beck JR, Kitahara T, et al. Reanalysis of unruptured intracranial aneurysm management: Effect of a new international study on the threshold probabilities. Med Decis Making 2001;21:87-96 (Pubitemid 32318759)
153. Vindlacheruvu RR, Mendelow AD, Mitchell P. Riskbenefit analysis of the treatment of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2005;76: 234-239 (Pubitemid 40143714)
154. Yoshimoto Y, Wakai S. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms: A mathematical model. Stroke 1999;30: 1621-1627 (Pubitemid 29379613)
155. Yoshimoto Y. A mathematical model of the natural history of intracranial aneurysms: Quantification of the benefit of prophylactic treatment. J Neurosurg 2006;104: 195-200
156. Johnston SC, Zhao S, Dudley RA, et al. Treatment of unruptured cerebral aneurysms in California. Stroke 2001;32:597-605
157. Higashida RT, Lahue BJ, Torbey MT, et al. Treatment of unruptured intracranial aneurysms: A nationwide assessment of effectiveness. AJNR Am J Neuroradiol 2007;28:146-151 (Pubitemid 46147555)
158. Murayama Y, Nien YL, Duckwiler G, et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years experience. J Neurosurg 2003;98:959-966 (Pubitemid 36460885)
159. Brilstra EH, Rinkel GJ, van der Graaf Y, et al. Treatment of intracranial aneurysms by embolization with coils: A systematic review. Stroke 1999;30:470-476 (Pubitemid 29071820)
160. Tsutsumi K, Ueki K, Usui M, et al. Risk of subarachnoid hemorrhage after surgical treatment of unruptured cerebral aneurysms. Stroke 1999;30:1181-1184 (Pubitemid 29259170)